Literature DB >> 1869819

In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes.

J K Lazdins1, T Klimkait, K Woods-Cook, M Walker, E Alteri, D Cox, N Cerletti, R Shipman, G Bilbe, G McMaster.   

Abstract

In vitro-differentiated monocytes can be infected with the monocytotropic isolate of HIV-1/ADA. The infection is characterized by formation of giant cells and production of virus that can be found in cell supernatants or cell-associated. In this study, we demonstrate that the above described parameters of infection can be enhanced by a factor present in acidified M phi supernatants, suggesting that it might be transforming growth factor beta-1 (TGF-beta 1). When recombinant or purified TGF-beta were examined, similar activities were detected. This effect apparently is not because of changes in the cellular phenotype that could favor infection. The effect of TGF-beta is exerted on cells once infection is established or on cells with active virus production. The activity can be also demonstrated using U-937 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869819

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

Authors:  C J De Haas; N M de Vos; M R Visser; H Snippe; J Verhoef
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.

Authors:  F Hamy; E R Felder; G Heizmann; J Lazdins; F Aboul-ela; G Varani; J Karn; T Klimkait
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis.

Authors:  P Schmid; D Cox; G K McMaster; P Itin
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.

Authors:  Z Toossi; L Xia; M Wu; A Salvekar
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.

Authors:  D V Havlir; F J Torriani; R D Schrier; J Y Huang; M M Lederman; K A Chervenak; W H Boom
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.

Authors:  J M Li; X Shen; P P Hu; X F Wang
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  G Herbein; S Gordon
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.

Authors:  G Englund; T S Theodore; E O Freed; A Engelman; M A Martin
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 9.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

10.  Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells.

Authors:  G Poli; A L Kinter; J S Justement; P Bressler; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.